Travoprost FDA Link

A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Also Known As:

Travatan; (((1R)- (1alpha(Z),2beta(1E,3R*),3alpha,5alpha))- 7- (3,5- dihydroxy- 2- (3- hydroxy- 4- (3- trifluoromethyl)phenoxy)- 1- butenyl)cyclopentyl)- 5- heptenoic acid, 1-methylethyl ester; AL-6221; AL6221; Travatan Z; AL 6221; Z, Travatan

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Synthetic Prostaglandins: 823
        Synthetic Prostaglandins F: 2
        Cloprostenol: 60
        Travoprost: 338
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Synthetic Prostaglandins: 823
    - Synthetic Prostaglandins F: 2
      - Cloprostenol: 60
        Travoprost: 338
  - Autacoids: 276
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Synthetic Prostaglandins: 823
        Synthetic Prostaglandins F: 2
        Cloprostenol: 60
        Travoprost: 338

Ryan J Plyler Selected Research

Ryan J Plyler Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure